Sentences with phrase «clinical case study reports»

Not exact matches

There has been concern raised about a resurgence of vitamin D deficiency and rickets among infants and children, with reports emerging in the United States from Alaska, 1,2 Iowa, 3 Nevada, 4 California, 5 North Carolina, 6 Texas, 7 and mother - infant pairs in Boston, 8 among others.9 The prevalence of vitamin D deficiency in young children also appears to be high in other countries, including England, 10 Greece, 11 and Canada.12, 13 One study from China found a 65.3 % prevalence of vitamin D deficiency among 12 - to 24 - month - olds, but few cases (3.7 %) of radiographic or clinical rickets were noted.14 Previous studies suggest risk factors to be dark skin pigmentation1,3 - 12 and breastfeeding without supplementation.1 - 7, 9,12,13 To date, reports have focused primarily on young infants compared with toddlers.
Furthermore, the report accuses the British Homeopathic Association (BHA), which had submitted evidence to the panel, of cherry - picking, and even, in one case actively misrepresenting, research into the treatment (a famous study that concluded its findings were «compatible with the notion that the clinical effects of homeopathy are placebo effects» was cited by the BHA as evidence of the treatment's efficacy.)
In three new studies in the current issue of the International Journal of Infectious Disease, researchers reported on clinical outcomes in the Kingdom of Saudi Arabia (KSA), how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there.
The British Journal of Clinical Pharmacology analysis included 49 case reports and two observational studies with 15 cases of adverse drug reactions.
Her 1990 case - control study, reported in the Journal of Clinical Epidemiology, found no association between aluminum - containing products and Alzheimer's disease.
He said the new study demonstrates the power of liquid biopsies of resistant cancers to identify the biological causes and — in the present casereport those mechanisms simultaneously with the publication of the clinical trial results for a new drug.
In a rare move, the companies that make the multiple sclerosis drug daclizumab (brand name Zinbryta) have voluntarily pulled the medication from the market and stopped all clinical studies after reports of eight cases of serious brain inflammation among patients in Europe.
Of the 34 published reports with sufficient clinical information on at least 1 component of CZS, 11 were single case descriptions,13 - 23 21 case series,10,24 - 43 1 cohort study, 44 and 1 case - control study.7 Two reports contain information on pregnancies in French Polynesia24, 29 and 29 in Brazil; and there were 2 such reports in the United States13, 15 and 1 in Spain, 20 with exposure outside the countries of birth.
This species has a history of use in traditional Chinese medicine and although there have been anecdotal reports of benefits, there have been no clinical controlled studies to test the efficacy of this herb (herb, here referring to a general term that may be either a plant, root, mold, and in this case, a parasite.)
We support veterinary practitioners worldwide through a network of experts that provide advice on cases, continuing education opportunities, a high - quality scientific journal, educational resources and assistance in the design and reporting of clinical studies.
In a recent retrospective study of 70 dogs with fatal pancreatitis the following clinical signs were reported: anorexia in 91 % of the cases, vomiting in 90 %, weakness in 79 %, abdominal pain in 58 %, dehydration in 46 %, and diarrhea in 33 %.
-- Updated case reports and source documents for clinical trials, arranged study interviews, and recruitment — Updated medical records, maintained information on protocol and case reports for each trial, developed flow sheets and identified subject eligibility — Performed QA / QC procedures, worksheets and study materials, collected data and ordered supplies — Prepared consent amendments and processed specimens — Prepared sponsor files for FDA compliance and GCP guidelines
Assisted other therapeutic teams with processing case report forms (CRF) from various clinical studies and spontaneous consumer reports
Group Pension and Administrators (Richardson, TX) 2007 — 2010 Medical Data / Reporting Analyst • Implemented tactics to decreased time for generating specialized reports by 50 % on clinical financial research • Researched case studies needing Benefit Modelers and benchmark resulting in efficient aid in negotiations and cost analysis • Analyzed / interpreted data, problem solved, and communicated solutions for a variety of issues across multiple departments • Provided multiple solutions for cost drivers using medical related software showing cause and effect relationships
Many of the scales demonstrated weak psychometrics in at least one of the following ways: (a) lack of psychometric data [i.e., reliability and / or validity; e.g., HFQ, MASC, PBS, Social Adjustment Scale - Self - Report (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e., clinical) «cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting studies of children with pediatric physical conditions because physical symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child - report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsiReport (SAS - SR) and all perceived self - esteem and self - concept scales], (b) items that fall on more than one subscale (e.g., CBCL - 1991 version), (c) low alpha coefficients (e.g., below.60) for some subscales, which calls into question the utility of using these subscales in research and clinical work (e.g., HFQ, MMPI - A, CBCL - 1991 version, BASC, PSPCSAYC), (d) high correlations between subscales (e.g., PANAS - C), (e) lack of clarity regarding clinically - relevant cut - off scores, yielding high false positive and false negative rates (e.g., CES - D, CDI) and an inability to distinguish between minor (i.e., subclinical) and major (i.e., clinical) «cases» of a disorder (e.g., depression; CDI, BDI), (f) lack of correspondence between items and DSM criteria (e.g., CBCL - 1991 version, CDI, BDI, CES - D, (g) a factor structure that lacks clarity across studies (e.g., PSPCSAYC, CASI; although the factor structure is often difficult to assess in studies of pediatric populations, given the small sample sizes), (h) low inter-rater reliability for interview and observational methods (e.g., CGAS), (i) low correlations between respondents such as child, parent, teacher [e.g., BASC, PSPCSAYC, CSI, FSSC - R, SCARED, Connors Ratings Scales - Revised (CRS - R)-RSB-, (j) the inclusion of somatic or physical symptom items on mental health subscales (e.g., CBCL), which is a problem when conducting studies of children with pediatric physical conditions because physical symptoms may be a feature of the condition rather than an indicator of a mental health problem, (k) high correlations with measures of social desirability, which is particularly problematic for the self - related rating scales and for child - report scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsireport scales more generally, and (l) content validity problems (e.g., the RCMAS is a measure of anxiety, but contains items that tap mood, attention, peer interactions, and impulsivity).
Includes case studies and clinical reports that describe innovative evaluation and intervention techniques with persons with developmental and physical disabilities
a b c d e f g h i j k l m n o p q r s t u v w x y z